HEALTH ECONOMICS AND POLICY ADVISORY
Established in 2021, Zeumed is a health economics and policy consulting company specialising in advising governments and payers.
​
​
​
Our expertise includes health financing reform, econometric modelling, cost-benefit analysis, health investment opportunities, and healthcare policy evaluation.
​
​
We work with
​
​​
-
national health care payers
-
governments and Ministries of Health
-
insurers and reinsurers
-
NGOs in the health sector
-
entrepreneurs involved in bringing medical technology or devices to market
-
health sector and life science investors
​
Experience has shown that financial health and patient care go hand-in-hand. Her team performs deep-dives into cost data with an approach that is similar to the granularity used in clinical practice. We are skilled in translating complex economic concepts into actionable insights for decision makers in healthcare. We provide
​
-
Robustness testing of health economic submissions, including value based payment models, both for providers and payers.
-
Advice on the use of materially important indicators for payment models.
-
Reviews of digital health tenders to ensure alignment with payer priorities.
-
Formulation of market entry strategies for medtech and medical device companies taking national reimbursement strategies into consideration.
-
Clinical and economic reviews of investment opportunities in healthcare and life science.
Expertise
Health Economic Outcomes Research & Real World Evidence Generation
Insights into Clinical Technology Innovation
Health financing in fragile states
Value-Based Payment Design
Multilingual with global reach
Future proofing for health budgets
Founder and CEO
Dr Fiona Kiernan
-
Extensive clinical and economic experience which spans global health systems, national health systems, health payers, regulators, and life science.
-
Subject matter expert in health pricing and claims analysis, particularly in value-based healthcare.
-
Commercial acumen with background working with both startups and global life science and healthcare corporations.
-
Hybrid clinician/economist, with seventeen years as a practising doctor and a PhD in economics.
-
Leads cross functional teams of economists, data scientists and policy advisors working on complex health system issues.
-
Non-executive director for health agencies.
-
Featured in health industry journals, industry podcasts and national media.